Q: Would appreciate it if you could comment on the latest results for Nova Leap Health. A microcap with lots of risk, however, they certainly seem to be moving in the right direction. Thanks as always.
HALIFAX, Nova Scotia, Nov. 07, 2019 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a 2019 TSX Venture 50™ ranked company focused on the home health care industry, is pleased to announce the release of record financial results for the third quarter ended September 30, 2019. All amounts are in United States dollars unless otherwise specified.
Nova Leap Third Quarter of 2019
Highlights for the quarter ended September 30, 2019 included the following:
Nova Leap’s financial results for Q3 2019 are the best in the Company’s history;
Record quarterly EBITDA of $324,676 in Q3 2019 was an increase of 685% over Q3 2018 EBITDA of $41,357 and an increase of 49.2% over Q2 2019 EBITDA of $217,549;
HALIFAX, Nova Scotia, Nov. 07, 2019 (GLOBE NEWSWIRE) -- NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a 2019 TSX Venture 50™ ranked company focused on the home health care industry, is pleased to announce the release of record financial results for the third quarter ended September 30, 2019. All amounts are in United States dollars unless otherwise specified.
Nova Leap Third Quarter of 2019
Highlights for the quarter ended September 30, 2019 included the following:
Nova Leap’s financial results for Q3 2019 are the best in the Company’s history;
Record quarterly EBITDA of $324,676 in Q3 2019 was an increase of 685% over Q3 2018 EBITDA of $41,357 and an increase of 49.2% over Q2 2019 EBITDA of $217,549;